SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-001893
Filing Date
2021-05-11
Accepted
2021-05-11 17:00:36
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_10q-033121.htm 10-Q 278828
2 CERTIFICATION xenetic_ex3101.htm EX-31.1 9563
3 CERTIFICATION xenetic_ex3102.htm EX-31.2 9706
4 CERTIFICATION xenetic_ex3201.htm EX-32.1 4738
  Complete submission text file 0001683168-21-001893.txt   1735132

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20200331.xml EX-101.INS 191031
6 XBRL SCHEMA FILE xbio-20200331.xsd EX-101.SCH 24396
7 XBRL CALCULATION FILE xbio-20200331_cal.xml EX-101.CAL 30322
8 XBRL DEFINITION FILE xbio-20200331_def.xml EX-101.DEF 101493
9 XBRL LABEL FILE xbio-20200331_lab.xml EX-101.LAB 157535
10 XBRL PRESENTATION FILE xbio-20200331_pre.xml EX-101.PRE 138235
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 21912239
SIC: 2834 Pharmaceutical Preparations